Icon

CLEOCIN HYDROCHLORIDE (nda050162)- (EQ 75MG BASE,EQ 150MG BASE,EQ 300MG BASE)

CLINDAMYCIN HYDROCHLORIDE PFIZER
EQ 75MG BASE,EQ 150MG BASE,EQ 300MG BASE
No No
Expired Expired
None None
None No
Clindamycin is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci.
9 0 7
Total Other Developers 1
Drugs with Suitability No
EQ 75MG BASE ** ** - - 3
EQ 150MG BASE ** ** - - 4
EQ 300MG BASE ** ** - - 4
NDA Sales Available Total Generic Sales Available
Yes 4
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ****** *** ***** ************ ******* *********** ****** **. ***, *** *** ***, ******* ***** *. *. **. ** *******-*******, ******-****** *********, *********, ******* ******, ***** (***) ***
****** ********* ********* ********* *************** *******, ***. *********** ** ******* *****, *** ***** ******, *******, *** **** (**) *****, ****** ****** (***) ***
****** ***** **** ***** **** ******* *********** **** **. *-*** ** *-*** & **, ***** *** & ***** **, ***** ********** ******, *****, *** ******, ***** (***) ***
****** ******** ****** *** ******** *************** ******* *********** **** **. *, *****-*, ****** **** *** *********, ****, ****** ******* ******, ***** (***) ***
****** ******* ******* ***************, ***. *********** *** ******** ******, ***** **********, *** ****** (**) *****, ****** ****** (***) ***
****** *** ***** **** *** *** ************ ***. *********** **** ********** ***, ***** *********, *** ****** (**) *****, ****** ****** (***) ***
****** *** ***** **** *** *** ************** ********** ******* *********** *****-****** *******, *****, ******* ******, ***** (***) ***
****** *** ***** **** *** *** ************ ***. *********** ** ******** ****, *** *********, *** ****** (**) *****, ****** ****** (***) ***
****** ******* ******* *******, ***. *********** **** ********** ******, ************, ************ (**) *****, ****** ****** (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, **. **.*** & ***, **********, ********** ******, *******-********** ********, *******, ********* ******, ***** (***) ***
****** **** ****** *** ****** *************** ** *** ****, *** *********** ** ********** **, **********, *** **** (**) *****-****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.